Preliminary Results in Aliskiren Trial Show Drug ‘May Even Be Harmful’

thumb3_orange_pills

Preliminary results from the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) do not support administration of aliskiren on top of standard therapy with renin-angiotensin-aldosterone system (RAAS) blockade.

Read more

Posted in Drugs Medical Research Type II